Similar articles

• Markers of immune activation and viral load in HIV-associated sensory neuropathy.

  Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, McClernon DR, Conant K, Cohen B, Epstein LG, Kieburtz K; NEAD Consortium. Schifitto G, et al. Neurology. 2005 Mar 8;64(5):842-8. doi: 10.1212/01.WNL.0000152981.32057.BB. Neurology. 2005. PMID: 15753420
• Incidence of and risk factors for HIV-associated distal sensory polyneuropathy.

  Keswani SC, Hoke A. Keswani SC, et al. Neurology. 2003 Jul 22;61(2):279; author reply 279-80. doi: 10.1212/wnl.61.2.279. Neurology. 2003. PMID: 12874429 No abstract available.
• Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.

  Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T, Gelman BB, Vaida F, Collier A, Marra CM, Ances B, Atkinson JH, Dworkin RH, Morgello S, Grant I; CHARTER Study Group. Ellis RJ, et al. Arch Neurol. 2010 May;67(5):552-8. doi: 10.1001/archneurol.2010.76. Arch Neurol. 2010. PMID: 20457954 Free PMC article.
• Antiviral treatment of human immunodeficiency virus infection: update for 2003.

  Postic B, Horvath JA, Talwani R. Postic B, et al. J S C Med Assoc. 2003 Jun;99(6):148-53. J S C Med Assoc. 2003. PMID: 12886699 Review.
• Distal sensory polyneuropathy in the context of HIV/AIDS.

  Nicholas PK, Mauceri L, Slate Ciampa A, Corless IB, Raymond N, Barry DJ, Viamonte Ros A. Nicholas PK, et al. J Assoc Nurses AIDS Care. 2007 Jul-Aug;18(4):32-40. doi: 10.1016/j.jana.2007.05.003. J Assoc Nurses AIDS Care. 2007. PMID: 17662922 Review.